What’s Gotten Into These Stocks? Hansen Medical, Inc. (HNSN), Intuitive Surgical, Inc. (ISRG)

Second, investors likely see PacBio as a possible acquisition target. This is especially true after Roche threw in the towel on buying Illumina, Inc. (NASDAQ:ILMN) in the first few days of 2013. Roche chairman Franz Humer commented that his company had other options besides Illumina. Some think that Roche might still buy Illumina, but Humer said that a deal “is definitively off the table.” If so, PacBio could be among those on the table.

Another reason for interest in the stock could stem from insider activity. PacBio CEO Michael Hunkapiller bought more than $1.4 million worth of shares in November and December. Hunkapiller, along with CFO Susan Barnes, also agreed to receive only $1 in salary for 2013. Many investors take notice when a CEO puts his own money at stake.

Time to get in?
Whatever has gotten into these stocks has handsomely rewarded investors thus far in 2013. Is it time for those who haven’t bought shares to get in on these quick movers?

The answer to that question is “maybe.” These are speculative plays that many investors will want to avoid. However, some might be willing to take the risk for the possible returns that could come, especially if either company is acquired. Just remember that what (or who) has gotten into these stocks could just as quickly get out.

The article What’s Gotten Into These Stocks? originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Illumina, Intuitive Surgical, and Pacific Biosciences of California. The Motley Fool owns shares of Intuitive Surgical.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.